Piper Jaffray Companies started coverage on shares of OrthoPediatrics Corp. (NASDAQ:KIDS) in a research note issued to investors on Monday. The firm issued an overweight rating and a $24.00 price objective on the stock.

Shares of OrthoPediatrics Corp. (NASDAQ KIDS) traded down $1.31 during trading on Monday, reaching $20.51. 40,989 shares of the company’s stock traded hands, compared to its average volume of 251,916. OrthoPediatrics Corp. has a twelve month low of $17.03 and a twelve month high of $23.00.

ILLEGAL ACTIVITY NOTICE: This piece of content was originally reported by The Cerbat Gem and is the property of of The Cerbat Gem. If you are reading this piece of content on another domain, it was stolen and republished in violation of international trademark and copyright laws. The original version of this piece of content can be accessed at https://www.thecerbatgem.com/2017/11/07/orthopediatrics-corp-kids-now-covered-by-analysts-at-piper-jaffray-companies.html.

In related news, Director Harold Ruf bought 11,500 shares of the company’s stock in a transaction on Monday, October 16th. The stock was acquired at an average cost of $13.00 per share, for a total transaction of $149,500.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink.

About OrthoPediatrics Corp.

OrthoPediatrics Corp. is a medical device company. The Company designs, develops and commercializes orthopedic implants and instruments to meet the specialized needs of pediatric surgeons and their patients. It operates through the OrthoPediatrics segment, which designs, develops and markets implants and devices for children with orthopedic problems.

Receive News & Stock Ratings for OrthoPediatrics Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OrthoPediatrics Corp. and related stocks with our FREE daily email newsletter.